• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Glofitamab Antibody

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818613

Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells. Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells. Glofitamab can be used for the palliation of… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Glofitamab, Antibody
Full Product Name
Glofitamab
Product Synonym Names
RO7082859; RG 6026; CD20-TCB
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
2229047-91-8

Other Notes

Small volumes of anti-Glofitamab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Glofitamab purchase

MBS5818613 is an antibody targeting Glofitamab.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000